2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Factor VIIa
  5. Factor VIIa Inhibitor

Factor VIIa Inhibitor

Factor VIIa Inhibitors (4):

Cat. No. Product Name Effect Purity
  • HY-16382
    PCI-27483
    		Inhibitor 99.10%
    PCI-27483 is a FVIIa/tissue factor inhibitor, with antitumour effects.
  • HY-153480A
    ARC19499 sodium
    		Inhibitor 99.40%
    ARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 sodium blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 sodium corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
  • HY-153480
    ARC19499
    		Inhibitor
    ARC19499 is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
  • HY-153480C
    ARC19499 sodium scrambled negative control
    		Inhibitor
    ARC19499 sodium scrambled negative control is the sequence scrambled negative control of ARC19499 sodium.